Sanderling Ventures
Sanderling is an investment firm founded in 1979 focused on early-stage biomedical financing and active management. The firm partners closely with entrepreneurs to build new biomedical companies, providing specialized investment focus, active operational involvement and long-term capital commitments.
Sanderling Ventures
San Mateo, California, United States, North America
Services
Early-stage biomedical financing
Provides capital to new biomedical start-ups; emphasis on early-stage investments.
Active management and board participation
Takes active management roles, provides management team members and serves as directors for portfolio companies.
Long-term capital commitment
Commits capital and management support over extended time horizons to build companies.
Specialized sector expertise
Provides sector-specific guidance based on deep experience in biomedical areas including therapeutics, devices and platform technologies.
Early-stage biomedical financing
Provides capital to new biomedical start-ups; emphasis on early-stage investments.
Active management and board participation
Takes active management roles, provides management team members and serves as directors for portfolio companies.
Long-term capital commitment
Commits capital and management support over extended time horizons to build companies.
Specialized sector expertise
Provides sector-specific guidance based on deep experience in biomedical areas including therapeutics, devices and platform technologies.
Portfolio
Acquired by Guidant Corp. (now Boston Scientific); NYSE: BSX referenced
#Not specified on source
Acquired by Guidant Corp. (now Boston Scientific); NYSE: BSX referenced
#Not specified on source